Read This Before Selling Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Shares




  • In Business
  • 2020-09-16 14:32:57Z
  • By Simply Wall St.
Read This Before Selling Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Shares
Read This Before Selling Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Shares  

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we'll take a look at whether insiders have been buying or selling shares in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

What Is Insider Buying?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, rules govern insider transactions, and certain disclosures are required.

Insider transactions are not the most important thing when it comes to long-term investing. But it is perfectly logical to keep tabs on what insiders are doing. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise'.

See our latest analysis for Allscripts Healthcare Solutions

The Last 12 Months Of Insider Transactions At Allscripts Healthcare Solutions

Over the last year, we can see that the biggest insider purchase was by CEO & Director Paul Black for US$252k worth of shares, at about US$7.47 per share. That means that an insider was happy to buy shares at around the current price of US$8.62. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. In this case we're pleased to report that the insider purchases were made at close to current prices.

Allscripts Healthcare Solutions insiders may have bought shares in the last year, but they didn't sell any. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

Allscripts Healthcare Solutions is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that Allscripts Healthcare Solutions insiders own 1.5% of the company, worth about US$21m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Do The Allscripts Healthcare Solutions Insider Transactions Indicate?

It doesn't really mean much that no insider has traded Allscripts Healthcare Solutions shares in the last quarter. However, our analysis of transactions over the last year is heartening. Insiders own shares in Allscripts Healthcare Solutions and we see no evidence to suggest they are worried about the future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. In terms of investment risks, we've identified 1 warning sign with Allscripts Healthcare Solutions and understanding it should be part of your investment process.

But note: Allscripts Healthcare Solutions may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

COMMENTS

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business